LEADER 04249nam  2200661 a 450 
001 9910781779703321
005 20230725050847.0
010   $a0-309-20927-7
010   $a1-283-21341-9
010   $a9786613213419
010   $a0-309-20925-0
035   $a(CKB)2550000000043067
035   $a(EBL)3564221
035   $a(SSID)ssj0000540457
035   $a(PQKBManifestationID)11385832
035   $a(PQKBTitleCode)TC0000540457
035   $a(PQKBWorkID)10585933
035   $a(PQKB)10063822
035   $a(MiAaPQ)EBC3564221
035   $a(Au-PeEL)EBL3564221
035   $a(CaPaEBR)ebr10488618
035   $a(CaONFJC)MIL321341
035   $a(OCoLC)746930292
035   $a(EXLCZ)992550000000043067
100   $a20110824d2011      ua             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aProtecting the frontline in biodefense research $ethe Special Immunizations Program /$fNational Research Council of the National Academies
210   $aWashington, D.C. $cNational Academies Press$dc2011
215   $a1 online resource (183 p.)
300   $a"Committee on Special Immunizations Program for Laboratory Personnel Engaged in Research on Countermeasures for Selected Agents, Board on Life Sciences, Division on Earth and Life Studies."
311 1 $a0-309-20924-2 
320   $aIncludes bibliographical references.
327   $a""Front Matter""; ""Acknowledgments""; ""Contents""; ""Summary""; ""1 Introduction""; ""2 History of the Special Immunizations Program and Lessons Learned from Occupational Immunization Against Hazardous Pathogens""; ""3 The U.S. Medical Countermeasures Enterprise and Recent Reviews and Current Operation of the Special Immunizations Program""; ""4 Regulations and Other Guidance Pertaining to the Development and Use of Vaccines in the Special Immunizations Program""; ""5 New Vaccine Development and the Future Needs of the Special Immunizations Program""
327   $a""6 Potential Options for the Special Immunizations Program and for Personnel Immunization""""7 Conclusions and Recommendations""; ""References""; ""Appendixes""; ""Appendix A: Committee Member Biographies""; ""Appendix B: Abbreviations and Acronyms""; ""Appendix C: Glossary""
330   $a"The U.S. Army's Special Immunizations Program is an important component of an overall biosafety program for laboratory workers at risk of exposure to hazardous pathogens. The program provides immunizations to scientists, laboratory technicians and other support staff who work with certain hazardous pathogens and toxins. Although first established to serve military personnel, the program was expanded through a cost-sharing agreement in 2004 to include other government and civilian workers, reflecting the expansion in biodefense research in recent years. Protecting the Frontline in Biodefense Research examines issues related to the expansion of the Special Immunizations Program, considering the regulatory frameworks under which the vaccines are administered, how additional vaccines might be considered for inclusion in the Program, and factors that might influence the development and manufacturing of vaccines for the Special Immunizations Program."--Publisher's description.
606   $aBiological warfare$xResearch$xSafety measures
606   $aBiological warfare$xResearch$xHealth aspects
606   $aVaccines$zUnited States
606   $aMedicine, Military$zUnited States
615  0$aBiological warfare$xResearch$xSafety measures.
615  0$aBiological warfare$xResearch$xHealth aspects.
615  0$aVaccines
615  0$aMedicine, Military
676   $a358.38
712 02$aNational Research Council (U.S.).$bCommittee on Special Immunizations Program for Laboratory Personnel Engaged in Research on Countermeasures for Selected Agents.
712 02$aNational Research Council (U.S.).$bBoard on Life Sciences.
712 02$aNational Research Council (U.S.).$bDivision on Earth and Life Studies.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910781779703321
996   $aProtecting the frontline in biodefense research$93760298
997   $aUNINA